# Archit Organosy (NSE: ARCHITORG) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/ARCHITORG · Pivot · prices to 22 Oct 2026

With a market capitalisation of ₹117 Cr, it ranks 2577th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Chemicals sector; its industry is Chemicals.

Its return on equity was 5.1% in FY24. In Q4 FY24, the quarter ended 31 Mar 2024, revenue was ₹31 Cr (−33.4% year on year) and net profit ₹2 Cr (−7.7%), on a consolidated basis. Promoters held 65.88% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Market cap | ₹117 Cr |
| ROE | 5.1% (FY24) |
| ROCE | 4.8% (FY24) |
| Debt to equity | 0.4 |

## Quarterly results (₹ crore, consolidated)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q4 FY24 | ₹31 Cr | −33.4% | ₹2 Cr | −7.7% | ₹0.87 |
| Q3 FY24 | ₹25 Cr | +10.7% | −₹0 Cr | −120.6% | −₹0.22 |
| Q2 FY24 | ₹26 Cr | −7.3% | ₹0 Cr | −87.9% | ₹0.18 |
| Q1 FY24 | ₹31 Cr | +2.1% | ₹2 Cr | −61.9% | ₹0.77 |
| Q4 FY23 | ₹47 Cr | +77.1% | ₹2 Cr | +3.7% | ₹0.94 |
| Q3 FY23 | ₹22 Cr | −42.1% | ₹2 Cr | +9.9% | ₹1.09 |
| Q2 FY23 | ₹28 Cr | — | ₹3 Cr | — | ₹1.49 |
| Q1 FY23 | ₹30 Cr | — | ₹4 Cr | — | ₹2.01 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY24 | ₹113 Cr | ₹3 Cr |
| FY23 | ₹128 Cr | ₹11 Cr |
| FY08 | ₹21 Cr | ₹0 Cr |
| FY07 | ₹19 Cr | ₹0 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 65.88%
- Non-institutions: 34.12%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Tyche Ind](https://app.pivotnow.in/stock/TYCHE) | — | ₹131 Cr | — | — |
| [Vital Chemtech](https://app.pivotnow.in/stock/VITAL) | ₹53.39 | ₹128 Cr | 124.2 | — |
| [Standard Industries](https://app.pivotnow.in/stock/SIL) | ₹19.30 | ₹124 Cr | — | — |
| [Ishan Dyes and Chemicals](https://app.pivotnow.in/stock/ISHANCH) | ₹44.80 | ₹122 Cr | — | — |
| [Basant Agro Tec](https://app.pivotnow.in/stock/BASANTGL) | — | ₹111 Cr | — | — |
| [ShreeOswal Seeds And Chemicals](https://app.pivotnow.in/stock/OSWALSEEDS) | ₹12.00 | ₹110 Cr | 30.8 | — |

## Questions and answers

### What is the market cap of Archit Organosy?

Archit Organosy's market capitalisation is ₹117 Cr (₹117 Cr) at the 22 Oct 2026 close, ranking 2577th among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Archit Organosy?

Return on equity was 5.1% in FY24 and return on capital employed was 4.8% in FY24 (consolidated figures).

### Is Archit Organosy a debt-free company?

No. Archit Organosy's debt-to-equity ratio was 0.4 in FY24, with total debt of ₹8 Cr.

### What were Archit Organosy's latest quarterly results?

For Q4 FY24 (quarter ended 31 Mar 2024), Archit Organosy reported revenue of ₹31 Cr, −33.4% year on year, and net profit of ₹2 Cr, −7.7% year on year.

### What is the shareholding pattern of Archit Organosy?

As of 30 Jun 2026: promoters 65.88%, non-institutions 34.12%.

### Who are Archit Organosy's competitors?

The listed Chemicals companies closest to Archit Organosy by market cap are Tyche Ind, Vital Chemtech, Standard Industries, Ishan Dyes and Chemicals, Basant Agro Tec and ShreeOswal Seeds And Chemicals.

### Is Archit Organosy a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Archit Organosy's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on ARCHITORG against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.